questionsmedicales.fr
Composés chimiques organiques
Composés nitrés
Nitrophénols
Nitrophénols : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Nitrophénols : Questions médicales les plus fréquentes",
"headline": "Nitrophénols : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Nitrophénols : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-30",
"dateModified": "2025-04-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Nitrophénols"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés nitrés",
"url": "https://questionsmedicales.fr/mesh/D009574",
"about": {
"@type": "MedicalCondition",
"name": "Composés nitrés",
"code": {
"@type": "MedicalCode",
"code": "D009574",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dinitrophénols",
"alternateName": "Dinitrophenols",
"url": "https://questionsmedicales.fr/mesh/D004140",
"about": {
"@type": "MedicalCondition",
"name": "Dinitrophénols",
"code": {
"@type": "MedicalCode",
"code": "D004140",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.304"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "2,4-Dinitro-phénol",
"alternateName": "2,4-Dinitrophenol",
"url": "https://questionsmedicales.fr/mesh/D019297",
"about": {
"@type": "MedicalCondition",
"name": "2,4-Dinitro-phénol",
"code": {
"@type": "MedicalCode",
"code": "D019297",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.304.250"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "2-Bromométhyl-4-nitro-phénol",
"alternateName": "2-Hydroxy-5-nitrobenzyl Bromide",
"url": "https://questionsmedicales.fr/mesh/D015077",
"about": {
"@type": "MedicalCondition",
"name": "2-Bromométhyl-4-nitro-phénol",
"code": {
"@type": "MedicalCode",
"code": "D015077",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Niclofolan",
"alternateName": "Niclofolan",
"url": "https://questionsmedicales.fr/mesh/D009533",
"about": {
"@type": "MedicalCondition",
"name": "Niclofolan",
"code": {
"@type": "MedicalCode",
"code": "D009533",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitroxinil",
"alternateName": "Nitroxinil",
"url": "https://questionsmedicales.fr/mesh/D009611",
"about": {
"@type": "MedicalCondition",
"name": "Nitroxinil",
"code": {
"@type": "MedicalCode",
"code": "D009611",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.620"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Picrates",
"alternateName": "Picrates",
"url": "https://questionsmedicales.fr/mesh/D010851",
"about": {
"@type": "MedicalCondition",
"name": "Picrates",
"code": {
"@type": "MedicalCode",
"code": "D010851",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.690"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tolcapone",
"alternateName": "Tolcapone",
"url": "https://questionsmedicales.fr/mesh/D000077867",
"about": {
"@type": "MedicalCondition",
"name": "Tolcapone",
"code": {
"@type": "MedicalCode",
"code": "D000077867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.845"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Nitrophénols",
"alternateName": "Nitrophenols",
"code": {
"@type": "MedicalCode",
"code": "D009596",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sk Aftabul Alam",
"url": "https://questionsmedicales.fr/author/Sk%20Aftabul%20Alam",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, The University of Burdwan, Golapbag, Burdwan, West Bengal 713104 India."
}
},
{
"@type": "Person",
"name": "Pradipta Saha",
"url": "https://questionsmedicales.fr/author/Pradipta%20Saha",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, The University of Burdwan, Golapbag, Burdwan, West Bengal 713104 India."
}
},
{
"@type": "Person",
"name": "Yu Wang",
"url": "https://questionsmedicales.fr/author/Yu%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Shanghai Key Laboratory of Agricultural Genetics and Breeding, Agro-Biotechnology Research Institute, Shanghai Academy of Agricultural Sciences, Shanghai, 201106, China."
}
},
{
"@type": "Person",
"name": "Jin Li",
"url": "https://questionsmedicales.fr/author/Jin%20Li",
"affiliation": {
"@type": "Organization",
"name": "Institute for Environmental and Climate Research, Jinan University, Guangzhou 511443, China; Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality, Guangzhou 511443, China."
}
},
{
"@type": "Person",
"name": "Peizeng Yang",
"url": "https://questionsmedicales.fr/author/Peizeng%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Department of Environmental Science and Engineering, Nanjing Agricultural University, Nanjing 210095, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer.",
"datePublished": "2022-09-05",
"url": "https://questionsmedicales.fr/article/36131933",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.911325"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-type lectin domain-containing protein CLEC3A regulates proliferation, regeneration and maintenance of nucleus pulposus cells.",
"datePublished": "2022-07-21",
"url": "https://questionsmedicales.fr/article/35864364",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00018-022-04477-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human Milk Oligosaccharide 2'-Fucosyllactose Inhibits Ligand Binding to C-Type Lectin DC-SIGN but Not to Langerin.",
"datePublished": "2022-11-25",
"url": "https://questionsmedicales.fr/article/36499067",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms232314745"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inflammatory Mesenchymal Stem Cells Express Abundant Membrane-Bound and Soluble Forms of C-Type Lectin-like CD248.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37298499",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24119546"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association between c-type lectin-like receptor 2 and microsatellite instability in colorectal cancer: a cross-sectional study.",
"datePublished": "2022-07-28",
"url": "https://questionsmedicales.fr/article/35902826",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12885-022-09834-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés nitrés",
"item": "https://questionsmedicales.fr/mesh/D009574"
},
{
"@type": "ListItem",
"position": 4,
"name": "Nitrophénols",
"item": "https://questionsmedicales.fr/mesh/D009596"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Nitrophénols - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Nitrophénols",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Nitrophénols",
"description": "Comment diagnostiquer une intoxication aux nitrophénols ?\nQuels tests sont utilisés pour évaluer l'exposition ?\nQuels symptômes indiquent une intoxication ?\nLes nitrophénols sont-ils détectables par imagerie ?\nY a-t-il des marqueurs biologiques spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Lectins,+C-Type&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Nitrophénols",
"description": "Quels sont les symptômes d'une exposition aiguë ?\nLes nitrophénols provoquent-ils des effets chroniques ?\nComment les nitrophénols affectent-ils le système respiratoire ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nLes symptômes varient-ils selon la dose ?",
"url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Lectins,+C-Type&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Nitrophénols",
"description": "Comment prévenir l'exposition aux nitrophénols ?\nLes travailleurs doivent-ils être formés ?\nQuelles sont les mesures de sécurité en laboratoire ?\nLes nitrophénols sont-ils réglementés ?\nComment gérer les déversements de nitrophénols ?",
"url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Lectins,+C-Type&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Nitrophénols",
"description": "Quel est le traitement principal en cas d'intoxication ?\nDes antidotes existent-ils pour les nitrophénols ?\nComment traiter les irritations cutanées causées par les nitrophénols ?\nLe charbon actif est-il utile en cas d'ingestion ?\nQuand faut-il hospitaliser un patient exposé ?",
"url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Lectins,+C-Type&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Nitrophénols",
"description": "Quelles complications peuvent survenir après une exposition ?\nLes effets sont-ils réversibles ?\nY a-t-il un risque de cancer lié aux nitrophénols ?\nComment surveiller les complications à long terme ?\nLes complications varient-elles selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Lectins,+C-Type&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Nitrophénols",
"description": "Quels sont les principaux facteurs de risque d'exposition ?\nLes antécédents médicaux influencent-ils le risque ?\nLes enfants sont-ils plus à risque ?\nL'environnement joue-t-il un rôle ?\nLes habitudes de vie influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Lectins,+C-Type&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux nitrophénols ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins pour détecter les nitrophénols."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'exposition ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour mesurer les niveaux de nitrophénols."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées, et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Les nitrophénols sont-ils détectables par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'imagerie ne détecte pas les nitrophénols; des tests biochimiques sont nécessaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques spécifiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présence de métabolites spécifiques dans l'urine peut indiquer une exposition."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une exposition aiguë ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent des vertiges, des nausées, et des irritations cutanées."
}
},
{
"@type": "Question",
"name": "Les nitrophénols provoquent-ils des effets chroniques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition chronique peut entraîner des troubles neurologiques et hépatiques."
}
},
{
"@type": "Question",
"name": "Comment les nitrophénols affectent-ils le système respiratoire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des irritations des voies respiratoires et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les enfants ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes plus graves, comme des convulsions et des vomissements."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la dose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux nitrophénols ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Les travailleurs doivent-ils être formés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle."
}
},
{
"@type": "Question",
"name": "Quelles sont les mesures de sécurité en laboratoire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des hottes, des gants et des lunettes de protection lors de la manipulation."
}
},
{
"@type": "Question",
"name": "Les nitrophénols sont-ils réglementés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur utilisation est réglementée pour minimiser les risques d'exposition."
}
},
{
"@type": "Question",
"name": "Comment gérer les déversements de nitrophénols ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des kits de déversement et suivre les protocoles d'urgence appropriés."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal en cas d'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est l'élimination de l'exposition et le soutien symptomatique."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les nitrophénols ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique; le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées causées par les nitrophénols ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut rincer la zone affectée à l'eau et appliquer des crèmes apaisantes."
}
},
{
"@type": "Question",
"name": "Le charbon actif est-il utile en cas d'ingestion ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le charbon actif peut être administré pour réduire l'absorption en cas d'ingestion."
}
},
{
"@type": "Question",
"name": "Quand faut-il hospitaliser un patient exposé ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hospitalisation est nécessaire en cas de symptômes graves ou d'exposition prolongée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des lésions hépatiques, des troubles neurologiques et respiratoires."
}
},
{
"@type": "Question",
"name": "Les effets sont-ils réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de cancer lié aux nitrophénols ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens médicaux réguliers et des tests fonctionnels sont recommandés pour le suivi."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon l'âge ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants et les personnes âgées peuvent être plus vulnérables aux complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en chimie, les laboratoires et les sites industriels sont à risque élevé."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies hépatiques ou respiratoires augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en raison de leur taille et de leur métabolisme, les enfants sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre près d'industries utilisant des nitrophénols augmente le risque d'exposition."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines habitudes, comme le tabagisme, peuvent exacerber les effets des nitrophénols."
}
}
]
}
]
}
Immunotherapies, such as immune-checkpoint blockade and adoptive T-cell therapy, offer novel treatment options with good efficacy for patients with urothelial bladder cancer. However, heterogeneity an...
It is widely assumed that as connective tissue, the intervertebral disc (IVD) plays a crucial role in providing flexibility for the spinal column. The disc is comprised of three distinct tissues: the ...
Human milk oligosaccharides (HMOs) and their most abundant component, 2'-Fucosyllactose (2'-FL), are known to be immunomodulatory. Previously, it was shown that HMOs and 2'-FL bind to the C-type lecti...
CD248 (endosialin) belongs to a glycoprotein family that also includes thrombomodulin (CD141), CLEC14A, and CD93 (AA4) stem cell markers. We analyzed the regulated expression of CD248 in vitro using s...
As a transmembrane protein, C-type lectin-like receptor 2 (CLEC-2) is mainly expressed on platelets and released into plasma after platelet activation. Activated platelets participate in the regulatio...
A cross-sectional analysis of 430 CRC patients from Harbin Medical University Cancer Hospital was conducted. CLEC-2 levels were measured with fasting venous blood samples drawn from each participant b...
CLEC-2 levels were significantly higher among patients with high microsatellite instability phenotype than the stable microsatellite group, adjusting for other confounding variables....
The increased CLEC-2 is associated with the high microsatellite instability subtype of CRC....
Lectins are a large group of proteins found in many snake venoms. BjcuL is a C-type lectin from Bothrops jararacussu snake venom that does not present cytotoxicity action on human peripheral blood mon...
Capsular polysaccharides are common virulence factors of extracellular, but not intracellular bacterial pathogens, due to the antiphagocytic properties of these surface structures. It is therefore par...
SARS-CoV-2 causes COVID-19, an infectious disease with symptoms ranging from a mild cold to severe pneumonia, inflammation, and even death. Although strong inflammatory responses are a major factor in...
Tumor cell-induced platelet aggregation (TCIPA) is a mechanism for the protection of tumor cells in the bloodstream and the promotion of tumor progression and metastases. The platelet C-type lectin-li...
This study aimed to investigate the expression and clinical significance of Dendritic cell-associated C-type lectin-1 (Dectin-1) in gastric cancer (GC), and to explore the mechanism of Dectin-1 regula...
The association of Dectin-1...
High infiltration of intratumoral Dectin-1...
Dectin-1 could affect T-cell anti-tumour immune response by regulating the immunosuppressive function of TAMs, leading to poor prognosis and immune evasion in GC patients. Blockade of Dectin-1 can be ...